Leerink Partners reiterated an Outperform rating and $20.00 price target on Evolent Health (NYSE: EVH) following the company's call with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Unusual 11 Mid-Day Movers 7/13: (CNR) (IMPR) (OSHC) Higher; (BCEI) (AVGR) (LEDS) LowerJuly 13, 2016 12:57 PM Streetinsider.com's Hot Lunchtime Reads 7/13: (VRX) (EVH) (ADTN) (FB)July 13, 2016 12:06 PM FBR Capital Raises Price Target on Evolent Health (EVH) to $24 Following Valence Health Acquisitions July 13, 2016 11:16 AM Evolent Health (EVH) to Acquire Valence Health in $145M DealJuly 13, 2016 8:52 AM Evolent Health to Acquire Valence Health, Extending Breadth and Depth of Value-Based Care OfferingJuly 13, 2016 6:00 AM